Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
ActRule, addiction, addressed, Alliance, Alto, ASC, Asia, ASUNo, Aviron, bankruptcy, Bombay, brain, capecitabine, CDC, cited, codified, commensurate, complementary, curve, cut, dataset, deterrent, die, difficulty, disadvantage, dissolution, divested, domain, Drr, elapsed, eribulin, evolving, female, fluorouracil, FOLFIRI, frequency, Ghosh, Greer, Halaven, havelow, Hematidetm, IMS, inclusion, Iniparib, instability, IssueNo, Kearney, La, leucovorin, Levadextm, liposomal, marker, Median, misuse, mitigation, modestly, mu, ofRegulation, onForm, overdose, oxaliplatin, Palo, panitumumab, persuade, PLD, prescription, prevalence, proceeding, progressed, proven, purification, put, quantity, RECIST, recurrence, Reddy, Relistor, repatriated, reproductive, retreatment, Rinko, Salix, Sanofi, Scott, SECRule, Simon, skin, slower, South, stimulating, subset, suite, thisForm, tied, title, traditional, treasury, underRule, underwriter, Underwriting, Union, unusual, Vanderbilt, variable, verification, Wharton, Winger, withF
Filing tables
Filing exhibits
Related press release
NKTR similar filings
Filing view
External links
Exhibit 21.1
Subsidiaries of Nektar Therapeutics*
Jurisdiction of | ||
Incorporation or | ||
Name | Organization | |
Nektar Therapeutics UK, Ltd. | United Kingdom | |
Nektar Therapeutics (India) Pvt. Ltd | India |
* | Includes subsidiaries that do not fall under the definition of “Significant Subsidiary” as defined under Rule 1-02(w) of Regulation S-X. |
99